A detailed history of Morgan Stanley transactions in Apyx Medical Corp stock. As of the latest transaction made, Morgan Stanley holds 15,843 shares of APYX stock, worth $25,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,843
Previous 17,293 8.38%
Holding current value
$25,982
Previous $23,000 17.39%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.01 - $1.46 $1,464 - $2,117
-1,450 Reduced 8.38%
15,843 $19,000
Q2 2024

Oct 17, 2024

SELL
$1.26 - $1.66 $3,342 - $4,403
-2,653 Reduced 13.3%
17,293 $23,000
Q2 2024

Aug 14, 2024

SELL
$1.26 - $1.66 $3,342 - $4,403
-2,653 Reduced 13.3%
17,293 $23,000
Q1 2024

Oct 17, 2024

BUY
$1.25 - $2.71 $3,316 - $7,189
2,653 Added 15.34%
19,946 $27,000
Q1 2024

Aug 16, 2024

BUY
$1.25 - $2.71 $3,500 - $7,588
2,800 Added 16.33%
19,946 $27,000
Q1 2024

May 15, 2024

BUY
$1.25 - $2.71 $3,500 - $7,588
2,800 Added 16.33%
19,946 $27,000
Q4 2023

Aug 16, 2024

SELL
$1.49 - $3.25 $219 - $477
-147 Reduced 0.85%
17,146 $44,000
Q4 2023

Feb 13, 2024

SELL
$1.49 - $3.25 $1,877 - $4,095
-1,260 Reduced 6.85%
17,146 $44,000
Q3 2023

Nov 15, 2023

BUY
$3.07 - $6.2 $6,103 - $12,325
1,988 Added 12.11%
18,406 $58,000
Q2 2023

Aug 14, 2023

SELL
$2.75 - $7.59 $458,416 - $1.27 Million
-166,697 Reduced 91.03%
16,418 $82,000
Q1 2023

May 15, 2023

SELL
$2.45 - $3.59 $238,644 - $349,687
-97,406 Reduced 34.72%
183,115 $527,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $5.02 $330,437 - $1.18 Million
236,027 Added 530.47%
280,521 $656,000
Q3 2022

Nov 14, 2022

SELL
$4.49 - $10.83 $9,590 - $23,132
-2,136 Reduced 4.58%
44,494 $200,000
Q2 2022

Oct 27, 2022

BUY
$3.11 - $7.5 $88,426 - $213,247
28,433 Added 156.25%
46,630 $272,000
Q2 2022

Aug 15, 2022

BUY
$3.11 - $7.5 $88,426 - $213,247
28,433 Added 156.25%
46,630 $272,000
Q1 2022

Oct 27, 2022

SELL
$5.87 - $13.13 $166,901 - $373,325
-28,433 Reduced 60.98%
18,197 $119,000
Q1 2022

May 13, 2022

SELL
$5.87 - $13.13 $86,153 - $192,709
-14,677 Reduced 44.65%
18,197 $119,000
Q4 2021

Feb 14, 2022

SELL
$12.15 - $17.4 $269,353 - $385,740
-22,169 Reduced 40.28%
32,874 $422,000
Q3 2021

Nov 15, 2021

BUY
$8.79 - $13.96 $483,827 - $768,400
55,043 New
55,043 $762,000

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $56.7M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.